CD44 and esophageal squamous cell carcinoma: Furthermore, C44Mab−46 also recognized endogenous CD44 in the context of ESCC cell lines as it reacted with both KYSE 70 and KYSE770 in a dose−dependent manner (Figure 2D,E).